LONGBOARD PHARMACEUTICALS IN shareholders Q3 2023

LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 52 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

LONGBOARD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,353,141$13,083,4640.76%
Integral Health Asset Management, LLC 760,000$4,225,6000.58%
Prosight Management, LP 321,154$1,785,6160.57%
Parkman Healthcare Partners LLC 355,957$1,979,1210.36%
Ikarian Capital, LLC 514,101$2,858,4010.34%
FARALLON CAPITAL MANAGEMENT LLC 1,560,500$8,676,3800.04%
Polar Capital Holdings Plc 1,000,000$5,560,0000.04%
UBS OCONNOR LLC 262,265$1,458,1930.04%
BOOTHBAY FUND MANAGEMENT, LLC 112,614$626,1340.02%
Point72 Asset Management, L.P. 825,000$4,587,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 7,000$38,9200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 50,000$278,0000.01%
Woodline Partners LP 81,279$451,9110.01%
Dorsey Wright & Associates 3,045$16,9300.01%
MOORE CAPITAL MANAGEMENT, LP 45,728$254,2480.01%
Schonfeld Strategic Advisors LLC 84,000$467,0400.00%
CIBC Asset Management Inc 144,571$803,8150.00%
TD ASSET MANAGEMENT INC 121,422$675,1060.00%
Tower Research Capital LLC (TRC) 4,295$23,8800.00%
FMR LLC 2,113,073$11,748,6860.00%
External links

This page lists LONGBOARD PHARMACEUTICALS IN's shareholders in Q3 2023. To view LONGBOARD PHARMACEUTICALS IN's shareholder history, click here.